Sands Capital's position in Amphenol Corp. is currently worth $91.5 Million. That's 0.26% of their equity portfolio (51st largest holding). The stake costed the investor $63.5 Million, netting the investor a gain of 44% so far.
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” fourth-quarter investor letter. A copy o...
https://www.investing.com/news/pro/amphenol-pt-raised-to-80-at-rbc-capital-432SI-2923438
RBC Capital Stick to Their Hold Rating for Amphenol Corp
GAINERS: MGC Pharmaceuticals (PINK: MGCLF ) shares closed up 42.86% at $0.02 Australis Capital (OTCQB: AUSAF ) shares closed up 42.68% at $0.12 Zelira Therap...